The GBSI BioPolicy Summit is an annual forum to discuss the many issues that arise in biomedical research which need to be discussed among all stakeholders in order to enact industry wide policies.
Our 2014 Inaugural Summit focused on cancer research by recognizing the transformative impact cell authentication can have in improving cancer study replication. We shared key recommendations developed by GBSI’s Cell Authentication and Standards Task Force, including the role public and private funders can have on improving the quality and efficacy of research.
Leaders from academia, government agencies, industry, patient advocacy groups, publishing, and the funding community joined together to discuss new policies and best practices to fuel the development of life-saving treatments. It featured an interactive panel discussion that was moderated by Richard Harris, NPR Science Correspondent, who also led a question-and-answer session about how new policies and best practices will promote breakthroughs in cancer research.
Download the Program Download the Summary
555 Pennsylvania Ave NW,
Washington, DC 20001
Leonard P. Freedman, PhD, President, GBSI
Keith Yamamoto, PhD, Vice Chancellor for Research, University of California,
San Francisco, and Executive Vice Dean, UCSF School of Medicine
• Véronique Kiermer, PhD
Executive Editor, Nature Publishing Group
• Jon R. Lorsch, PhD
Director, National Institute of General Medical Sciences, National Institutes of Health
• Richard M. Neve, PhD
Scientist, Discovery Oncology, Genentech
• Howard R. Soule, PhD
Chief Science Officer, Prostate Cancer Foundation and Senior Fellow, Milken Institute